APA (7th ed.) Citation

MB, O., S, V., JH, v. d. B., JJ, L. v. B., T, V., JG, v. d. W., . . . WK, B. (2011). Epidermal growth factor receptor (EGFR) antibody-induced antibody-dependent cellular cytotoxicity plays a prominent role in inhibiting tumorigenesis, even of tumor cells insensitive to EGFR signaling inhibition. Journal of immunology (Baltimore, Md. : 1950), 187(6), 3383. https://doi.org/10.4049/jimmunol.1003926

Chicago Style (17th ed.) Citation

MB, Overdijk, Verploegen S, van den Brakel JH, Lammerts van Bueren JJ, Vink T, van de Winkel JG, Parren PW, and Bleeker WK. "Epidermal Growth Factor Receptor (EGFR) Antibody-induced Antibody-dependent Cellular Cytotoxicity Plays a Prominent Role in Inhibiting Tumorigenesis, Even of Tumor Cells Insensitive to EGFR Signaling Inhibition." Journal of Immunology (Baltimore, Md. : 1950) 187, no. 6 (2011): 3383. https://doi.org/10.4049/jimmunol.1003926.

MLA (9th ed.) Citation

MB, Overdijk, et al. "Epidermal Growth Factor Receptor (EGFR) Antibody-induced Antibody-dependent Cellular Cytotoxicity Plays a Prominent Role in Inhibiting Tumorigenesis, Even of Tumor Cells Insensitive to EGFR Signaling Inhibition." Journal of Immunology (Baltimore, Md. : 1950), vol. 187, no. 6, 2011, p. 3383, https://doi.org/10.4049/jimmunol.1003926.